Stopped: Sponsor decided to terminate study early solely due to slow enrollment.
Study Objective is to establish the feasibility and safety of the NOVIS Transcarotid Neuroprotection System when used for the transcarotid intervention of patients that have a failed transfemoral endovascular therapy in the case of anterior circulation strokes due to large vessel embolic occlusions.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Number of Device-related Serious Adverse Events
Timeframe: 90 Days
Number of Other Serious Adverse Events
Timeframe: 90 Days
Number of Subjects With Functional Independence
Timeframe: 90 Days